The Indian pharmaceutical sector is projected to log a revenue growth of 8-10per cent this fiscal year, following a 10per cent growth last year, according to a CRISIL study.
Read More
On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
